Completed NA INTERVENTIONAL 1-arm NCT01687036

Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System

Sponsor: afreeze GmbH

Updated 9 times since 2017 Last updated: Nov 14, 2018 Started: Sep 30, 2012 Primary completion: Mar 31, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Atrial Fibrillation, this trial is completed. The trial is conducted by afreeze GmbH and has accumulated 9 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 4 earlier versions

Nov 2020 — Jan 2021 [monthly]

Completed NA
Jan 2019 — Nov 2020 [monthly]

Completed NA
Jun 2018 — Jan 2019 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Sep 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

afreeze GmbH

Data source: afreeze GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Innsbruck, Austria
• Linz, Austria